HZB receives financial support for improving the manufacturing process for CIGS solar cells
Sebastian Schmidt demonstrating one of the CIGS-Modules. © HZB
The Helmholtz-Zentrum Berlin (HZB) has pulled in a large project for further improving the manufacturing process for CIGS thin-film solar cells together with partners in Germany and from the Netherlands. The atmospheric pressure process operates without involving toxic gases and will be more economical. It will run under the acronym ACCESS-CIGS, which stands for “Atmospheric European Cooperation in Science and Technology (COST) Competitive Elemental Sulpho-Selenisation for CIGS”.
Experts at the Competence Centre Thin-Film- and Nanotechnology for Photovoltaics Berlin (PVcomB) in Adlershof are developing an innovative process to fabricate CIGS layers for application in thin-film solar cells. CIGS stands for the compound Cu(In,Ga)(Se,S)2, consisting of copper, indium, gallium, selenium and sulphur. Polycrystalline CIGS solar cell technology is noted for its high efficiencies at the solar-cell level and high energy yields for solar modules.
The process pursued at PVcomB does not require a vacuum and utilises elementary selenium and sulphur to convert the metallic precursor layer of copper-indium-gallium to a polycrystalline CIGS semiconductor layer. This has the advantage that the process can be carried out without the use of toxic gases such as hydrogen selenide (H2Se), saving on production costs. This might permit the manufacture of CIGS solar modules to be considerably more economical and thus support the currently difficult market situation.
PVcomB has been successful in attracting funding of 800 000 EUR under the SOLAR-ERA.NET Initiative. Staff will be working on the technology as part of a bi-national European consortium over the next two years to optimise the addition of selenium and improve its influence on the crystallisation process.
The project will be carried out in cooperation with the companies TNO/Solliance and Smit Thermal Solutions, both located in Eindhoven, Netherlands, and with the firm Dr. Eberl MBE Komponenten in Weil der Stadt on the German side.
- 5000th patient treated with protons for eye tumoursFor more than 20 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.
- Iridium-free catalysts for acid water electrolysis investigatedHydrogen will play an important role, both as a fuel and as a raw material for industry. However, in order to produce relevant quantities of hydrogen, water electrolysis must become feasible on a multi-gigawatt scale. One bottleneck is the catalysts required, with iridium in particular being an extremely rare element. An international collaboration has therefore investigated iridium-free catalysts for acidic water electrolysis based on the element cobalt. Through investigations with various methods, among them experiments at the LiXEdrom at the BESSY II X-ray source in Berlin, they were able to elucidate processes that take place during water electrolysis in a cobalt-iron-lead oxide material as the anode. The study is published in Nature Energy.
- Lithium-sulphur batteries with lean electrolyte: problem areas clarifiedUsing a non-destructive method, a team at HZB investigated practical lithium-sulphur pouch cells with lean electrolyte for the first time. With operando neutron tomography, they could visualise in real-time how the liquid electrolyte distributes and wets the electrodes across multilayers during charging and discharging. These findings offer valuable insights into the cell failure mechanisms and are helpful to design compact Li-S batteries with a high energy density in formats relevant to industrial applications.